Magdalena Dunowska

Equine adenovirus type 1 (EAdV-1) infection has been recognised among horses worldwide. The virus predominantly targets respiratory tract but has also been recovered from other body systems. The objective of the study was to determine the frequency of EAdV-1 infection among selected horse populations in Poland and to estimate genetic variability within the viruses obtained. A quantitative PCR assay targeting a partial hexon gene was used to screen 1150 nasal swabs collected from 1145 horses from 19 horse studs throughout Poland. The samples were collected opportunistically between 2012 and 2025. A set of PCR primers was designed to amplify and sequence a partial fibre gene from the qPCR-positive samples. Sequences from 1 to 5 clones from each PCR product were analysed using sequence identity matrix, phylogeny and median-joining haplotype networks. EAdV-1 was found in 49/1150 (4.3%) samples collected from 48 healthy horses and one horse showing clinical signs of respiratory disease. Partial fibre gene sequences from individual horses were closely related to each other. Sequences from each stud were closely related, even if they were collected over several years. Taken together, this study provides first insights into the epidemiology of active infections caused by EAdV-1 among horses from selected Polish studs, including genetic variability among the viruses detected.

Equid herpesvirus 5 (EHV-5) comprises a group of heterogeneous viruses with a worldwide distribution. Primary infection typically occurs early in life, which is followed by latency and periodic recrudescence of the virus. The aim of this study was to determine the genetic variation of EHV-5 in individual animals over time and to determine the dynamics of EHV-5 spread among selected mare–foal pairs at three horse studs. The partial glycoprotein B (gB) gene was amplified from archival nasal swab samples. Sequences from 3–5 clones from each PCR product were compared using identity matrix, phylogeny, and median-joining haplotype networks. Overall, 328 clones were sequenced from long PCR products amplified from 84 EHV-5 PCR-positive swabs. The sequences were heterogeneous (89.4% to 100% nucleotide identity). The EHV-5 sequences from mares and their foals most often clustered separately, although similar EHV-5 sequences from the same mare–foal pair were also recovered. For some animals, the EHV-5 sequences from multiple sampling times clustered together, while sequences from other animals were distributed throughout the networks. Clones from the same PCR product were most often similar to each other, but divergent clones from the same PCR product were also apparent. In conclusion, the foals were likely to acquire EHV-5 infection from sources other than their dams, but some exchange of EHV-5 between mares and their foals also occurred. Some foals likely acquired EHV-5 from a single source, while others from multiple sources. These data contribute to our understanding of EHV-5 variability and the dynamics of infection in individual horses.

To determine the genetic makeup of carnivore parvoviruses currently circulating in New Zealand; to investigate their evolutionary patterns; and to compare these viruses with those detected during the previous New Zealand-based survey (2009-2010). Faecal samples from dogs (n = 40) with a clinical diagnosis of parvovirus enteritis were voluntarily submitted by veterinarians from throughout New Zealand. In addition, one sample was collected from a cat with comparable clinical presentation. The samples were used for DNA extraction and PCR amplification of viral protein 2 (VP2) of canine parvovirus type 2 (CPV-2). All samples produced amplicons of the expected sizes, which were then sequenced. The viruses were subtyped based on the presence of specific amino acids at defined locations. In addition, VP2 sequences were analysed using phylogeny and molecular network analysis. The majority (30/40; 75%) of CPV-2-infected dogs were younger than 6 months and 8/40 (20%) were aged between 9 months and 1 year. Most (39/41; 95%) parvoviruses were subtyped as CPV-2c, and one as the original CPV-2. The faecal sample from a cat was positive for feline panleukopenia virus. The majority (37/39; 95%) of New Zealand CPV-2c viruses were monophyletic. The remaining two New Zealand CPV-2c viruses clustered with Chinese and Sri Lankan CPV-2c viruses, separately from the main New Zealand clade. There has been an apparent replacement of the CPV-2a viruses with CPV-2c viruses in New Zealand between 2011 and 2019. The source of the current CPV-2c viruses remains undetermined. The monophyletic nature of the majority of viruses detected most likely reflects a country-wide spread of the most successful genotype. However, an occasional introduction of CPV-2 from overseas cannot be excluded. Current vaccines appear to be protective against disease caused by the CPV-2c viruses currently circulating in New Zealand. Vaccination and protection from environmental sources of CPV-2 until the development of vaccine-induced immunity remains the cornerstone of protection in young dogs against parvovirus enteritis. Ongoing monitoring of the genetic changes in CPV-2 is important, as it would allow early detection of variants that may be more likely to escape vaccine-induced immunity.

Equine rhinitis A (ERAV) and B (ERBV) viruses are respiratory pathogens with worldwide distribution. The current study aimed to determine the frequency of infection of ERAV and ERBV among horses and foals at Polish national studs, and to determine genetic variability within the viruses obtained. Virus-specific quantitative RT-PCR assays targeting a 5′ untranslated region were used to screen nasal swabs collected from 621 horses at 16 national horse studs from throughout Poland, including 553 healthy horses and 68 horses with respiratory disease. A partial DNA polymerase gene was amplified and sequenced from the qRT-PCR-positive samples. The obtained sequences were analysed using phylogeny and genetic network analysis. None of the nasal swabs were positive for ERAV, whereas ERBV was found in 11/621 (1.78%) samples collected from 10 healthy horses and one foal affected by respiratory disease. Partial DNA polymerase gene sequence variability was correlated with individual horses and studs from which samples were collected when only Polish sequences were analysed, but there was no correlation between country of origin and ERBV sequence when Polish and international sequences were included in the network. The report presents the first detection of ERBV in Poland.

Wildlife is the source of many emerging infectious diseases. Several viruses from the order Nidovirales have recently emerged in wildlife, sometimes with severe consequences for endangered species. The order Nidovirales is currently classified into eight suborders, three of which contain viruses of vertebrates. Vertebrate coronaviruses (suborder Cornidovirineae ) have been extensively studied, yet the other major suborders have received less attention. The aim of this minireview was to summarize the key findings from the published literature on nidoviruses of vertebrate wildlife from two suborders: Arnidovirineae and Tornidovirineae . These viruses were identified either during investigations of disease outbreaks or through molecular surveys of wildlife viromes, and include pathogens of reptiles and mammals. The available data on key biological features, disease associations, and pathology are presented, in addition to data on the frequency of infections among various host populations, and putative routes of transmission. While nidoviruses discussed here appear to have a restricted in vivo host range, little is known about their natural life cycle. Observational field-based studies outside of the mortality events are needed to facilitate an understanding of the virus-host-environment interactions that lead to the outbreaks. Laboratory-based studies are needed to understand the pathogenesis of diseases caused by novel nidoviruses and their evolutionary histories. Barriers preventing research progress include limited funding and the unavailability of virus- and host-specific reagents. To reduce mortalities in wildlife and further population declines, proactive development of expertise, technologies, and networks should be developed. These steps would enable effective management of future outbreaks and support wildlife conservation.

In 2019 a novel coronavirus termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged from an unidentified source and spread rapidly among humans worldwide. While many human infections are mild, some result in severe clinical disease that in a small proportion of infected people is fatal. The pandemic spread of SARS-CoV-2 has been facilitated by efficient human-to-human transmission of the virus, with no data to indicate that animals contributed to this global health crisis. However, a range of domesticated and wild animals are also susceptible to SARS-CoV-2 infection under both experimental and natural conditions. Humans are presumed to be the source of most animal infections thus far, although natural transmission between mink and between free-ranging deer has occurred, and occasional natural transmission between cats cannot be fully excluded. Considering the ongoing circulation of the virus among people, together with its capacity to evolve through mutation and recombination, the risk of the emergence of animal-adapted variants is not negligible. If such variants remain infectious to humans, this could lead to the establishment of an animal reservoir for the virus, which would complicate control efforts. As such, minimising human-to-animal transmission of SARS-CoV-2 should be considered as part of infection control efforts. The aim of this review is to summarise what is currently known about the species specificity of animal coronaviruses, with an emphasis on SARS-CoV-2, in the broader context of factors that facilitate cross-species transmission of viruses.

One Health is a popular headline for an all-inclusive concept of our scientific work